共 34 条
[1]
Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW, Correction of the anemia of end‐stage renal disease with recombinant human erythropoietin. Results of a phase I and II clinical trial, N Engl J Med, 316, pp. 73-78, (1987)
[2]
Eschbach JW, Abdulhadi MH, Browne JK, Et al., Recombinant human erythropoietin in anemic patients with end‐stage renal disease. Results of a phase III multicenter clinical trial, Ann Intern Med, 111, pp. 992-1000, (1989)
[3]
Sundal E, Kaeser U, Correction of anaemia of chronic renal failure with recombinant human erythropoietin: Safety and efficacy of one year's treatment in a European multicenter study of 150 haemodialysis‐dependent patients, Nephrol Dial Transplant, 4, pp. 979-987, (1989)
[4]
Canadian Erythropoietin Study Group: Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis, Br Med J, 300, pp. 573-578, (1990)
[5]
Evans RW, Rader B, Manninen DL, The quality of life of hemodialysis recipients treated with recombinant human erythropoietin, JAMA, 263, pp. 825-830, (1990)
[6]
Robertson HT, Haley R, Guthrie M, Cardenas D, Eschbach JW, Adamson JW, Recombinant human erythropoietin improves exercise capacity in anemic hemodialysis patients, Am J Kidney Dis, 15, pp. 325-332, (1990)
[7]
Mayer G, Thum J, Cada EM, Stummvoll HK, Graf H, Working capacity is increased following recombinant human erythropoietin treatment, Kidney Int, 34, pp. 525-528, (1988)
[8]
Bommer J, Kugel M, Schwobel B, Ritz E, Barth HP, Seelig R, Improved sexual function during recombinant human erythropoietin therapy, Nephrol Dial Transplant, 5, pp. 204-207, (1990)
[9]
Brown AL, Tucker B, Baker LRI, Raine AEG, Seizures related to blood transfusion and erythropoietin treatment in patients undergoing dialysis, Br Med J, 299, pp. 1258-1259, (1989)
[10]
Edmunds ME, Walls J, Tucker B, Et al., Seizures in haemodialysis patients treated with recombinant human erythropoietin, Nephrol Dial Transplant, 4, pp. 1065-1069, (1989)